✦ LIBER ✦

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients

✍ Scribed by Yu Jin Kim; Hyun Chin Cho; Dong Hyun Sinn; Geum-Youn Gwak; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Joon Hyeok Lee

Book ID: 108954249
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 367 KB
Volume: 27
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2011.06852.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal dysfunction and hypophosphatemia d

Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B

✍ Mio Tanaka, Fumitaka Suzuki, Yuya Seko, Tasuku Hara… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 415 KB

High risk of renal impairment during lon

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B

✍ M. Viganò; P. Lampertico; M. Iavarone; G.E. Tontini; F. Facchetti; M. Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

HIGH RISK OF RENAL IMPAIRMENT DURING LON

HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

✍ M. Viganò; P. Lampertico; M. Iavarone; G.E. Tontini; F. Facchetti; M. Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

930 HIGH RISK OF RENAL IMPAIRMENT DURING

930 HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

✍ M. Viganó; P. Lampertico; M. Iavarone; G.E. Tontini; F. Facchetti; M. Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Long-term efficacy and safety of adefovi

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

✍ Patrick Marcellin; Ting-Tsung Chang; Seng G. Lee Lim; William Sievert; Myron Ton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Treatment of 171 patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) with adefovir dipivoxil (ADV) 10 mg over 48 weeks resulted in significant histological, virological, serological, and biochemical improvement compared with placebo. The long-term efficacy and safety of AD

Renal tubular dysfunction during long-te

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

✍ N. Gara; X. Zhao; M. T. Collins; W. H. Chong; D. E. Kleiner; T. Jake Liang; M. G 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB